Terms: = Lymphoma AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Diagnosis
3 results:
1. lck expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Ge L; Xu L; Lu S; Yan H
FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
[TBL] [Abstract] [Full Text] [Related]
2. The Use of Transcriptional Profiling to Improve Personalized diagnosis and Management of Cutaneous T-cell lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract] [Full Text] [Related]
3. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
Yeh CH; Abdool A; Bruey JM
Cancer Biomark; 2010; 7(6):295-303. PubMed ID: 21694468
[TBL] [Abstract] [Full Text] [Related]
